Table of Contents
ISRN Endocrinology
Volume 2013 (2013), Article ID 873507, 6 pages
http://dx.doi.org/10.1155/2013/873507
Research Article

Paradoxically Low Levels of Total and HMW Adiponectin in Relation to Metabolic Parameters in a Tongan Population

1Renal Laboratory, Department of Medicine, University of New South Wales, Randwick, NSW 2031, Australia
2Institute of Obesity, Nutrition and Exercise, Sydney University, Darlington, NSW 2006, Australia
3Garvan Institute of Medical Research, Sydney University, Darlinghurst, NSW 2010, Australia
4Royal North Shore Hospital, Sydney University, St Leonards, NSW 2065, Australia

Received 3 June 2013; Accepted 23 June 2013

Academic Editors: F. Escobar-Jimenez, E. Hajduch, S. M. Hileman, and J. A. Rillema

Copyright © 2013 Philip Peake et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Hara, T. Yamauchi, and T. Kadowaki, “Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans,” Current Diabetes Reports, vol. 5, no. 2, pp. 136–140, 2005. View at Google Scholar · View at Scopus
  2. U. B. Pajvani, M. Hawkins, T. P. Combs et al., “Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity,” Journal of Biological Chemistry, vol. 279, no. 13, pp. 12152–12162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Waki, T. Yamauchi, J. Kamon et al., “Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin,” Journal of Biological Chemistry, vol. 278, no. 41, pp. 40352–40363, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T.-S. Tsao, E. Tomas, H. E. Murrey et al., “Role of disulfide bonds in ACRP30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways,” Journal of Biological Chemistry, vol. 278, no. 50, pp. 50810–50817, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Yamauchi, J. Kamon, Y. Ito et al., “Cloning of adiponectin receptors that mediate antidiabetic metabolic effects,” Nature, vol. 423, no. 6941, pp. 762–769, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Yamauchi, Y. Nio, T. Maki et al., “Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions,” Nature Medicine, vol. 13, no. 3, pp. 332–339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Colagiuri, R. Colagiuri, S. Na'ati, S. Muimuiheata, Z. Hussain, and T. Palu, “The prevalence of diabetes in the Kingdom of Tonga,” Diabetes Care, vol. 25, no. 8, pp. 1378–1383, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Craig, K. Samaras, J. Freund, N. Culton, V. Halavatau, and L. Campbell, “BMI inaccurately reflects total body and abdominal fat in Tongans,” Acta Diabetologica, vol. 40, no. 1, supplement, pp. S282–S285, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Shand, P. Elder, R. Scott, C. Frampton, and J. Willis, “Biovariability of plasma adiponectin,” Clinical Chemistry and Laboratory Medicine, vol. 44, no. 10, pp. 1264–1268, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Shen, J. A. Charlesworth, J. J. Kelly, K. W. Loi, and P. W. Peake, “Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease,” Nephrology Dialysis Transplantation, vol. 22, no. 1, pp. 171–178, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. W. Peake, A. D. Kriketos, L. V. Campbell, Y. Shen, and J. A. Charlesworth, “The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals,” European Journal of Endocrinology, vol. 153, no. 3, pp. 409–417, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Pischon, G. S. Hotamisligil, and E. B. Rimm, “Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year,” Clinical Chemistry, vol. 49, no. 4, pp. 650–652, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Craig, V. Halavatau, E. Comino, and I. Caterson, “Differences in body composition between Tongans and Australians: time to rethink the healthy weight ranges?” International Journal of Obesity, vol. 25, no. 12, pp. 1806–1814, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Fujimatsu, N. Kotooka, T. Inoue, M. Nishiyama, and K. Node, “Association between high molecular weight adiponectin levels and metabolic parameters,” Journal of Atherosclerosis and Thrombosis, vol. 16, no. 5, pp. 553–559, 2009. View at Google Scholar · View at Scopus
  15. J. Krakoff, T. Funahashi, C. D. A. Stehouwer et al., “Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian,” Diabetes Care, vol. 26, no. 6, pp. 1745–1751, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kaser, T. Tatarczyk, A. Stadlmayr et al., “Effect of obesity and insulin sensitivity on adiponectin isoform distribution,” European Journal of Clinical Investigation, vol. 38, no. 11, pp. 827–834, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Lara-Castro, E. C. Doud, P. C. Tapia et al., “Adiponectin multimers and metabolic syndrome traits: relative adiponectin resistance in African Americans,” Obesity, vol. 16, no. 12, pp. 2616–2623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Cnop, P. J. Havel, K. M. Utzschneider et al., “Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex,” Diabetologia, vol. 46, no. 4, pp. 459–469, 2003. View at Google Scholar · View at Scopus
  19. N. L. Duarte, S. Colagiuri, T. Palu, X. L. Wang, and D. E. L. Wilcken, “Obesity, Type II diabetes and the β2 adrenoceptor gene Gln27Glu polymorphism in the Tongan population,” Clinical Science, vol. 104, no. 3, pp. 211–215, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Myles, R. A. Lea, J. Ohashi et al., “Testing the thrifty gene hypothesis: the Gly482Ser variant in PPARGC1A is associated with BMI in Tongans,” BMC Medical Genetics, vol. 12, article 10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Cesari, K. Narkiewicz, R. De Toni, E. Aldighieri, C. J. Williams, and G. P. Rossi, “Heritability of plasma adiponectin levels and body mass index in twins,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 8, pp. 3082–3088, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Menzaghi, V. Trischitta, and A. Doria, “Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease,” Diabetes, vol. 56, no. 5, pp. 1198–1209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Menzaghi, L. Salvemini, G. Paroni et al., “Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family-based study,” Journal of Internal Medicine, vol. 267, no. 3, pp. 287–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Shand, P. Elder, R. Scott, N. Poa, and C. M. Frampton, “Comparison of plasma adiponectin levels in New Zealand Māori and Caucasian individuals,” New Zealand Medical Journal, vol. 120, no. 1257, 2007. View at Google Scholar · View at Scopus
  25. M. Evans, R. C. Sinclair, C. Fusimalohi, and V. Liava'a, “Diet, health and the nutrition transition: some impacts of economic and socio-economic factors on food consumption patterns in the Kingdom of Tonga,” Pacific Health Dialog, vol. 9, no. 2, pp. 309–315, 2002. View at Google Scholar · View at Scopus
  26. H. M. Mavoa and M. McCabe, “Sociocultural factors relating to Tongans' and Indigenous Fijians' patterns of eating, physical activity and body size,” Asia Pacific Journal of Clinical Nutrition, vol. 17, no. 3, pp. 375–384, 2008. View at Google Scholar · View at Scopus
  27. E. H. Yeung, L. J. Appel, E. R. Miller, and W. H. L. Kao, “The effects of macronutrient intake on total and high-molecular weight adiponectin: results from the OMNI-heart trial,” Obesity, vol. 18, no. 8, pp. 1632–1637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. K. Heilbronn, S. Gregersen, D. Shirkhedkar, D. Hu, and L. V. Campbell, “Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes,” Diabetes, vol. 56, no. 8, pp. 2046–2053, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. W. L. Holland, R. A. Miller, Z. V. Wang et al., “Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin,” Nature Medicine, vol. 17, no. 1, pp. 55–63, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Maeda, I. Shimomura, K. Kishida et al., “Diet-induced insulin resistance in mice lacking adiponectin/ACRP30,” Nature Medicine, vol. 8, no. 7, pp. 731–737, 2002. View at Publisher · View at Google Scholar · View at Scopus